Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Abilify Maintena PI 23 May 2018
Tevatiapine XR PI 23 May 2018
Paclitaxin PI 23 May 2018
Reyataz PI 23 May 2018
Jevtana PI 23 May 2018

New products

Product name Type Date released
Abacavir/Lamivudine Mylan PI 23 May 2018
Rydapt CMI 23 May 2018
Rydapt PI 23 May 2018
Abacavir/Lamivudine Mylan CMI 23 May 2018
Everolimus Sandoz CMI 18 May 2018